AU2001242502A1 - Use of protease inhibitors in cosmetics and pharmacy - Google Patents

Use of protease inhibitors in cosmetics and pharmacy

Info

Publication number
AU2001242502A1
AU2001242502A1 AU2001242502A AU4250201A AU2001242502A1 AU 2001242502 A1 AU2001242502 A1 AU 2001242502A1 AU 2001242502 A AU2001242502 A AU 2001242502A AU 4250201 A AU4250201 A AU 4250201A AU 2001242502 A1 AU2001242502 A1 AU 2001242502A1
Authority
AU
Australia
Prior art keywords
pharmacy
cosmetics
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242502A
Inventor
Dr. Thomas Forster
Dirk Petersohn
Gunter Schmitt
Klaus Rudolf Schroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10020447A external-priority patent/DE10020447A1/en
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of AU2001242502A1 publication Critical patent/AU2001242502A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
AU2001242502A 2000-03-31 2001-03-22 Use of protease inhibitors in cosmetics and pharmacy Abandoned AU2001242502A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10016016 2000-03-31
DE10016016 2000-03-31
DE10020447 2000-04-26
DE10020447A DE10020447A1 (en) 2000-03-31 2000-04-26 Use of protease inhibitors in cosmetics and pharmacy
PCT/EP2001/003258 WO2001074320A2 (en) 2000-03-31 2001-03-22 Use of protease inhibitors in cosmetics and pharmacy

Publications (1)

Publication Number Publication Date
AU2001242502A1 true AU2001242502A1 (en) 2001-10-15

Family

ID=26005113

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242502A Abandoned AU2001242502A1 (en) 2000-03-31 2001-03-22 Use of protease inhibitors in cosmetics and pharmacy

Country Status (3)

Country Link
EP (1) EP1267813A2 (en)
AU (1) AU2001242502A1 (en)
WO (1) WO2001074320A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259014A1 (en) * 2002-12-16 2004-06-24 Henkel Kgaa Antioxidant combinations with 6,7-disubstituted 2,2-dialkylchromanes or chromenes
US7217690B2 (en) 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
DK2233127T3 (en) 2004-03-17 2020-08-24 Stada Arzneimittel Ag Use of antioxidants in the manufacture of a pharmaceutical or cosmetic composition to protect the skin from damage caused by infrared radiation
ES2310142B1 (en) 2007-06-15 2009-12-04 Lipotec S.A PIGMENTATION REGULATING COMPOUNDS.
EP2100594A1 (en) 2008-03-14 2009-09-16 Symrise GmbH & Co. KG Ternary mixtures with increased collagen synthesis
EP2113242A1 (en) * 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
CN108299372B (en) * 2018-04-09 2022-11-04 青岛新虹锐泽机械科技有限公司 Medicine for preventing and treating gingivitis and preparation method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188817A (en) * 1989-03-27 1993-02-23 Julius Ozick Method of treatment for periodontitis
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
GB9223235D0 (en) * 1992-11-05 1992-12-16 Unilever Plc Cosmetic composition
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1998036742A1 (en) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
FR2772618B1 (en) * 1997-12-18 2000-02-18 Ifremer USE OF FUCANE AS A REGULATOR OF CONJUNCTIVE TISSUE RECONSTRUCTION
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
DE19834355A1 (en) * 1998-07-30 2000-02-03 Henkel Kgaa Anti-inflammatory dentifrices
ES2154560B1 (en) * 1998-09-16 2001-12-01 Lipotec Sa COMPOSITION BASED ON CHROMAN DERIVATIVES AND ITS USE TO CHEMICALLY REDUCE OXIDATIVE OR INDUCED REACTIONS BY FREE RADICALS.
DE19903716A1 (en) * 1999-01-30 2000-08-03 Henkel Kgaa Antioxidant skin care products
JP3490658B2 (en) * 1999-04-19 2004-01-26 カネボウ株式会社 Whitening cosmetics
JP3933344B2 (en) * 1999-04-30 2007-06-20 ライオン株式会社 Hair cosmetics
FR2808189B1 (en) * 2000-04-28 2004-03-05 Oreal LIPOCHROMAN-6 AS NO-SYNTHASE INHIBITOR AND USES

Also Published As

Publication number Publication date
WO2001074320A2 (en) 2001-10-11
EP1267813A2 (en) 2003-01-02
WO2001074320A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU5002301A (en) Cosmetic compositions comprising exfoliating enzymes and uses thereof
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001233739A1 (en) Use of natural substances in the production of cosmetic preparations
AU2002361060A1 (en) Use of apple core extracts in cosmetic or pharmaceutical compositions
AU2001258381A1 (en) Use of parp inhibitors in cosmetic preparations
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
GB0022710D0 (en) Dispenser and method of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
AU2001257272A1 (en) Use of mmp inhibitors in filtering blebs and ischemia
AU2001242502A1 (en) Use of protease inhibitors in cosmetics and pharmacy
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001261375A1 (en) Human caspase-12 materials and methods
GB0200204D0 (en) Cosmetic and related preparations
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 11, PAGE(S) 2339-2354 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 47154/00, 47949/00, 51117/00, 74220/00, 20262/01, 20270/01, 25092/01, 40590/01, 42491/01, 42502/01, 46799/01, 48212/01, 48676/01, 50178/01, 50340/01, 50629/01, 55047/01, 56835/01, 57646/01, 60122/01, 62207/01 AND 68757/01